- Home
- HELE vs PHAT Comparison
HELE vs PHAT Comparison
Compare HELE & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HELE | PHAT |
|---|---|---|
| Founded | 1968 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.6M | 676.3M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HELE | PHAT |
|---|---|---|
| Price | $29.44 | $7.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $24.00 | $19.83 |
| AVG Volume (30 Days) | 315.1K | ★ 1.0M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.72 |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $1,478,845,000.00 | $175,110,000.00 |
| Revenue This Year | $1.78 | $93.04 |
| Revenue Next Year | $3.14 | $58.91 |
| P/E Ratio | $18.31 | ★ N/A |
| Revenue Growth | N/A | ★ 216.93 |
| 52 Week Low | $13.85 | $7.31 |
| 52 Week High | $30.68 | $18.31 |
Technical Indicators
Market Signals| Indicator | HELE | PHAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 33.83 |
| Support Level | $25.60 | N/A |
| Resistance Level | $28.90 | $9.74 |
| Average True Range (ATR) | 1.00 | 0.46 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 74.82 | 9.51 |
Price Performance
Historical ComparisonAbout HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.